University of California, Berkeley, School of Public Health, Berkeley, CA, USA.
YLabs Rwanda, Kigali, Rwanda.
Nat Med. 2024 Nov;30(11):3121-3128. doi: 10.1038/s41591-024-03205-1. Epub 2024 Aug 23.
We conducted a cluster-randomized hybrid effectiveness-implementation study of CyberRwanda, a digital family planning and reproductive health intervention for Rwandan adolescents. Sixty schools were randomized 1:1:1 to control or to one of two implementation models-self-service (self-guided access on tablets) or facilitated (peer-led clubs plus tablet access) with no masking. Eligible participants were aged 12-19 years, in secondary school levels 1 or 2, and willing to provide consent or assent/parental consent and contact information for follow-up. In 2021, 6,078 randomly selected adolescents were enrolled. At 24 months, 91.3% of participants were retained and included in the primary intention-to-treat analyses (control, n = 1,845; self-service, n = 1,849 and facilitated, n = 1,858). There were no adverse events related to the study. CyberRwanda did not affect the primary outcomes of modern contraceptive use (prevalence ratio (PR) = 1.04; 95% confidence interval (CI) = 0.76, 1.42), childbearing (PR = 1.33; 95% CI = 0.71, 2.50) and HIV testing (PR = 1.00; 95% CI = 0.91, 1.11) in the full sample. Significantly higher modern contraceptive use observed in the CyberRwanda facilitated arm in a prespecified analysis of sexually active participants suggests that longer-term evaluation is needed to examine effects as more of the study population becomes sexually active and has increased demand for contraception. ClinicalTrials.gov registration: NCT04198272 .
我们开展了一项关于 CyberRwanda 的集群随机混合有效性-实施研究,这是一项针对卢旺达青少年的数字化计划生育和生殖健康干预措施。60 所学校以 1:1:1 的比例随机分为对照组或两种实施模式组(自助服务,即平板电脑自助访问)或促进组(同伴主导的俱乐部加平板电脑访问),无掩蔽。合格参与者年龄在 12-19 岁之间,在中学 1 或 2 年级,愿意提供同意或同意/父母同意,并提供后续联系信息。2021 年,随机招募了 6078 名青少年。在 24 个月时,91.3%的参与者保留并纳入主要意向治疗分析(对照组,n=1845;自助服务组,n=1849 例和促进组,n=1858 例)。没有与研究相关的不良事件。CyberRwanda 没有影响主要结局的现代避孕措施使用率(流行率比(PR)=1.04;95%置信区间(CI)=0.76,1.42)、生育(PR=1.33;95%CI=0.71,2.50)和 HIV 检测(PR=1.00;95%CI=0.91,1.11)。在预先指定的活跃参与者分析中,CyberRwanda 促进组中观察到的现代避孕措施使用率显著更高,这表明需要进行更长期的评估,以检查随着更多的研究人群变得活跃并对避孕措施的需求增加,效果如何。ClinicalTrials.gov 注册:NCT04198272。